StockNews.com Begins Coverage on Streamline Health Solutions (NASDAQ:STRM)

Equities researchers at StockNews.com initiated coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research report issued on Wednesday. The firm set a “sell” rating on the stock.

Separately, Craig Hallum raised Streamline Health Solutions to a “strong-buy” rating in a research report on Thursday, September 5th.

Streamline Health Solutions Price Performance

Streamline Health Solutions stock opened at $2.58 on Wednesday. Streamline Health Solutions has a 52-week low of $1.85 and a 52-week high of $9.75. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 0.66. The firm’s fifty day moving average is $2.62 and its 200 day moving average is $5.30. The company has a market cap of $10.89 million, a price-to-earnings ratio of -0.52 and a beta of 1.67.

Streamline Health Solutions (NASDAQ:STRM) last announced its earnings results on Wednesday, September 11th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.15). Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%. The company had revenue of $4.48 million during the quarter.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.